S
Stoke Therapeutics, Inc.
STOK · NASDAQ · Healthcare · 2.0B
Closing price
$24.74
+3.30% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.2×
Enterprise value / EBITDAEV/EBITDA
-270.6×
Free cash flow yieldFCF yield
3.1%
Return on equityROE
-2.0%
Operating margin
-11.2%
Net debt / EBITDAbalance-sheet strength
15.9×
Interest coverage
-2287.8×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.